Trial Profile
A study to investigate neointimal stent strut coverage after implantation of drug-eluting stents
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Feb 2016
Price :
$35
*
At a glance
- Drugs Everolimus (Primary) ; Zotarolimus (Primary)
- Indications Coronary artery disease
- Focus Pharmacodynamics
- 16 Feb 2016 New trial record